Venezuela’s Earthquake Disaster: Paralyzed State and Collapsed Healthcare Magnify the Tragedy
Venezuela is facing a deepening humanitarian crisis after a powerful earthquake struck at approximately 6 p. m. local time on June 24.
Search results for "global"
MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem
South Korean biotechnology company MediPost has entered full-scale Phase 3 clinical testing in the United States for its landmark knee osteoarthritis...
Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio
Novartis is significantly expanding its oncology portfolio after securing an antibody-drug conjugate technology...
Japanese Medical Scholars Visit Daegu, Praising South Korea's Advanced Healthcare and Rich Cultural Heritage
South Korea’s advanced medical infrastructure and deep cultural heritage left a lasting impression on prominent figures...
Make Your Fingertips Pop for Summer Vacation: KATSEYE’s Playful Dot Nails
As summer vacation approaches, the desire to refresh your style right down to your fingertips naturally grows.
The 8 A.M. Miracle: How Parkside Rehabilitation Hospital Redesigns Lives After Acute Care
Every Wednesday and Friday, Parkside Rehabilitation Hospital—located near the UN Memorial Cemetery in Nam-gu,...
The Ultra-Processed Trap: Why a Healthy Diet Can’t Save Your Brain from Junk Food
Even if you strictly follow a nutrient-rich regimen like the Mediterranean diet, regularly consuming ultra-processed...
Heart Attack and Stroke Survivors Face Significantly Higher Long-Term Suicide Risk, Study Finds
While controlling blood pressure and cholesterol is traditionally considered the top priority after a heart attack or...
GC Biopharma to Conduct Phase 3 Clinical Trial for Two-Dose Chickenpox Vaccine in South Korea
GC Biopharma’s chickenpox vaccine, Barycela Inj., is set to enter a Phase 3 clinical trial in South Korea to confirm...
Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo
Daewoong Pharmaceutical’s proprietary type 2 diabetes treatment, Enblo (active ingredient: enavogliflozin), is set to...